Three years after its OrbiMed-backed series A in 2023, Sidewinder Therapeutics is adding to its nest egg courtesy of a clutch of new investors. The San Diego startup has sunk its teeth into a $137 ...
Adrian Woolfson and Kaihang Wang at the Informa Biotech Showcase. Updated January 26th with technology licensing information. A new technology elucidated yesterday in the journal Nature has the ...
Sidewinder Therapeutics secures $137M Series B to develop next-generation bispecific ADCs. The firm aims to target hard-to-treat cancers with enhanced tumour specificity. Funding will support pipeline ...
Sidewinder will use the money to progress its pipeline of bispecific ADCs to the clinic. Credit: SauliusJan / Shutterstock.com. Sidewinder Therapeutics has secured $137m in a Series B financing round ...
Sidewinder Therapeutics has raised $137 million in a Series B financing round that will be used to advance newer types of antibody-drug conjugates, or ADCs, into clinical testing. In Sidewinder’s case ...
Our look at the Artillery Sidewinder X3 Pro 3D printer continues with a look at setup, operations and software. This is part two of a three part series, please read parts one and three. Tramming the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results